Prediction of Nonadherence and Renal Prognosis by Pre-Transplantation Serum Phosphate Levels.


Journal

Annals of transplantation
ISSN: 2329-0358
Titre abrégé: Ann Transplant
Pays: United States
ID NLM: 9802544

Informations de publication

Date de publication:
10 May 2019
Historique:
entrez: 11 5 2019
pubmed: 11 5 2019
medline: 24 12 2019
Statut: epublish

Résumé

BACKGROUND Identifying characteristics of patients at high risk of poor adherence before transplantation would be advantageous. However, the optimal approach for characterizing such patients remains unknown. We aimed to evaluate the association between factors for hemodialysis nonadherence and post-transplant renal prognosis. We hypothesized that these factors would influence post-transplantation adherence and worsen renal prognosis. MATERIAL AND METHODS We reviewed patients on hemodialysis who underwent kidney transplantation at our hospital between 2000 and 2017 to identify risk factors associated with poor prognosis. The patients' background and pre-transplantation data, known hemodialysis nonadherence factors, serum phosphate and potassium levels, and interdialytic weight gains were evaluated. The primary endpoint was renal death. We also evaluated the fluctuation of calcineurin inhibitor concentration and weight gain after transplantation. RESULTS Seventy-seven patients were eligible, and the mean observational period was 83.2 months (standard deviation, 50.5). Thirteen patients reached the endpoint. Cox proportional hazards regression analysis showed that pre-transplantation serum phosphate level was a risk factor for renal death (p<0.05), while serum potassium levels and weight gain were not. In addition, fluctuation of calcineurin inhibitor concentration was observed in patients with higher phosphate levels before transplantation (p=0.03). Weight gain after transplantation was not associated with the hemodialysis nonadherence factors. CONCLUSIONS High pre-transplantation serum phosphate levels are considered to represent poor drug adherence and/or an unhealthy lifestyle. Patient education that conveys the importance of adhering to medications and provides nutritional guidance is crucial for improving post-transplantation renal prognosis.

Identifiants

pubmed: 31073118
pii: 914909
doi: 10.12659/AOT.914909
pmc: PMC6530439
doi:

Substances chimiques

Phosphates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

260-267

Références

Am J Kidney Dis. 2001 Feb;37(2):244-66
pubmed: 11157365
Am J Kidney Dis. 2001 Aug;38(2):349-53
pubmed: 11479161
J Clin Nurs. 2001 Sep;10(5):707-15
pubmed: 11822521
Kidney Int. 2003 Jul;64(1):254-62
pubmed: 12787417
Kidney Int Suppl. 2005 Jan;(93):S63-8
pubmed: 15613071
Am J Transplant. 2005 Dec;5(12):2922-8
pubmed: 16303006
Kidney Int. 2006 Jul;70(2):363-70
pubmed: 16738533
Transplantation. 2007 Apr 15;83(7):858-73
pubmed: 17460556
BMC Nephrol. 2008 Jan 31;9:2
pubmed: 18237373
Kidney Int Suppl. 2010 Dec;(119):S71-5
pubmed: 21116322
Clin J Am Soc Nephrol. 2011 Nov;6(11):2712-21
pubmed: 21959597
Kidney Int. 2012 Feb;81(3):247-55
pubmed: 22012131
Ther Apher Dial. 2013 Jun;17(3):247-88
pubmed: 23735142
Semin Dial. 2014 Jan-Feb;27(1):42-9
pubmed: 24164416
Transplantation. 2015 Feb;99(2):351-9
pubmed: 25594550
Clin Exp Nephrol. 2015 Dec;19(6):1184-8
pubmed: 25782729
Hemodial Int. 2016 Jan;20(1):38-49
pubmed: 25975222
Ann Transplant. 2015 Sep 24;20:569-75
pubmed: 26400681
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):694-703
pubmed: 26536899
Transplantation. 2016 Nov;100(11):2479-2485
pubmed: 26703349
Transplantation. 2017 Feb;101(2):430-436
pubmed: 26950724
Keio J Med. 2017 Sep 26;66(3):44-50
pubmed: 27990008
BMC Nephrol. 2017 Oct 23;18(1):318
pubmed: 29061163
Fundam Clin Pharmacol. 2018 Feb;32(1):88-97
pubmed: 29069531
Am J Kidney Dis. 2018 Mar;71(3):371-381
pubmed: 29198641
Br Med J. 1973 Dec 15;4(5893):643-6
pubmed: 4758544

Auteurs

Mineaki Kitamura (M)

Division of Blood Purification, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.
Department of Nephrology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Yasushi Mochizuki (Y)

Division of Blood Purification, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.
Department of Urology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Satoko Kitamura (S)

Division of Blood Purification, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.
Department of Nephrology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Yuta Mukae (Y)

Department of Urology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Hiromi Nakanishi (H)

Department of Urology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Yuki Ota (Y)

Department of Nephrology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Kumiko Muta (K)

Department of Nephrology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Hiroshi Yamashita (H)

Department of Nephrology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Yoko Obata (Y)

Department of Nephrology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Takahisa Iwata (T)

Department of Urology, Isahaya General Hospital, Isahaya, Nagasaki, Japan.

Masaharu Nishikido (M)

Department of Urology, Nagasaki Medical Center, Omura, Nagasaki, Japan.

Sachiko Kawanami (S)

Department of Nursing, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Miwa Takashima (M)

Division of Dietary Service, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Hitoshi Sasaki (H)

Hospital Pharmacy, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Hideki Sakai (H)

Division of Blood Purification, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.
Department of Urology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Hiroshi Mukae (H)

Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Nagasaki, Japan.

Tomoya Nishino (T)

Department of Nephrology, Nagasaki University Hospital, Nagasaki City, Nagasaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH